Do Terpenes Play a Role in the Stress-reducing Effects of a Forest Bathing Intervention?
2 other identifiers
interventional
43
1 country
1
Brief Summary
This pilot study evaluates the role terpenes play in the stress-reducing effects of a forest bathing intervention. Participants will participate in two interventions in random order: 1) terpene exposure and 2) no terpene exposure.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 9, 2022
CompletedFirst Posted
Study publicly available on registry
April 7, 2022
CompletedStudy Start
First participant enrolled
July 12, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 21, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
September 21, 2023
CompletedResults Posted
Study results publicly available
September 19, 2024
CompletedSeptember 19, 2024
August 1, 2024
1.2 years
March 9, 2022
June 15, 2024
August 21, 2024
Conditions
Outcome Measures
Primary Outcomes (2)
Changes in the HF (ms^2) Component of HRV
Assess whether VOC inhalation regulates psychophysiological outcomes of the terpenes-on vs. terpenes-off sessions. Ln High Frequency Heart Rate Variability at T2 (20 minutes into duration of exposure for each session)
At time point 2 (20 minutes into duration of exposure for Session 1 and Session 2 (which occurred at least 8 days after Session 1)).
Baseline HF (ms^2) Component of HRV
Assess whether VOC inhalation regulates psychophysiological outcomes of the terpenes-on vs. terpenes-off sessions. Ln High Frequency Heart Rate Variability at baseline.
At baseline (pre-exposure)
Secondary Outcomes (22)
Blood Pressure (Diastolic in mmHg)
At time point 4 (60 minutes into duration of exposure for Session 1 and Session 2 (which occurred at least 8 days after Session 1)).
Beats Per Minute (BPM)
At time point 4 (60 minutes into duration of exposure for Session 1 and Session 2 (which occurred at least 8 days after Session 1)).
Skin Conductance (μS)
At time point 2 (20 minutes into duration of exposure for Session 1 and Session 2 (which occurred at least 8 days after Session 1)).
Self-reported Positive Affect
At time point 2 (20 minutes into duration of exposure for Session 1 and Session 2 (which occurred at least 8 days after Session 1)).
Self-reported Stress
At time point 2 (20 minutes into duration of exposure for Session 1 and Session 2 (which occurred at least 8 days after Session 1)).
- +17 more secondary outcomes
Other Outcomes (1)
Degree of Association of Sum Composite of Absorbed Dose of VOCs in Serum (μg/mL)
Time point 4 (60 min) for absorbed dose associations with same time point for DBP, SBP, Cortisol, Il-6, TNF-alpha, and CRP; and associations with Time point 2 (20 minutes) for HRV, SCL, positive affect, negative affect, self-reported stress, heart rate.
Study Arms (2)
Terpenes On
EXPERIMENTALForest bathing intervention with no filtration of terpenes from inhaled air using PAPR with particle-only filter ("terpenes on")
Terpenes Off
ACTIVE COMPARATORForest bathing intervention with filtration of terpenes from inhaled air using PAPR with activated charcoal filter ("terpenes off")
Interventions
Participants will be seated in a forest environment for an hour-long exposure to the forest
Eligibility Criteria
You may qualify if:
- years and older
- Non-smoker
- Physically capable of walking for approximately 15-20 min from the study vehicle to the clinic and experimental locations.
You may not qualify if:
- Pregnancy
- Current or prior diagnosis of neurologic, hypertensive, psychiatric, respiratory disorder, or anosmia/hyposmia
- Some types of medication.
- Olfactory sensitivity threshold (assessed via UPSIT® test kit (Sensonics International, Haddon Heights, NJ)
- At enrollment, participants will complete a baseline survey on demographics, personality traits, and regular nature contact and perceptions. Study staff will also use the clinically-validated UPSIT® test kit (Sensonics International, Haddon Heights, NJ) to evaluate olfactory sensitivity and identify/exclude participants with undiagnosed smell loss.
- Study staff will work with participants to schedule their forest bathing sessions and review instructions on how to prepare (e.g., by avoiding alcohol, marijuana, and certain foods, drinks, and household cleaning products with high terpene concentrations 24 hrs before their session).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Pack Forest
Eatonville, Washington, 98328, United States
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Gregory Bratman
- Organization
- University of Washington
Study Officials
- PRINCIPAL INVESTIGATOR
Gregory Bratman, PhD
University of Washington
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Masking Details
- Participants and research staff conducting the intervention will be masked to the exposure
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor: Environmental and Forest Sciences
Study Record Dates
First Submitted
March 9, 2022
First Posted
April 7, 2022
Study Start
July 12, 2022
Primary Completion
September 21, 2023
Study Completion
September 21, 2023
Last Updated
September 19, 2024
Results First Posted
September 19, 2024
Record last verified: 2024-08